levonorgestrel has been researched along with Uterine Neoplasms in 65 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (9.23) | 18.7374 |
1990's | 3 (4.62) | 18.2507 |
2000's | 23 (35.38) | 29.6817 |
2010's | 27 (41.54) | 24.3611 |
2020's | 6 (9.23) | 2.80 |
Authors | Studies |
---|---|
Feng, W; Shen, Y; Yang, J; Yi, J | 1 |
Chen, L; de Meritens, AB; Hershman, DL; Hou, JY; Khoury-Collado, F; Matsuo, K; Melamed, A; St Clair, CM; Suzuki, Y; Wright, JD | 1 |
Chen, L; Lian, Y; Lin, T; Wu, Q; Yu, Y | 1 |
Lumbiganon, P; Pattanittum, P; Sangkomkamhang, US | 1 |
Boudova, B; Cindrova-Davies, T; Fanta, M; Kuzel, D; Lisa, Z; Mara, M; Zizka, Z | 1 |
Chang, YH; Chen, YJ; Hsu, TF; Huang, BS; Jiang, LY; Lin, CJ; Wang, PH | 1 |
Fujiwara, H; Matsubara, S; Morisawa, H; Narumi, R; Takei, Y; Taneichi, A | 1 |
Laopaiboon, M; Lumbiganon, P; Mol, BW; Sangkomkamhang, US | 1 |
Beltrame, A; Bernardes, CR; de Souza, IM; Machado, RB; Morimoto, MS; Santana, N | 1 |
Dutta, S; Jana, N; Rakshit, BM; Roy, SB; Saha, PK; Sengupta, G | 1 |
Cancelo Hidalgo, MJ | 1 |
Munro, MG; Solnik, MJ | 1 |
Bastianelli, C; Benagiano, G; Brosens, I; Farris, M | 1 |
Chen, M; Jiang, W; Shen, Q; Wang, Y; Zhou, Q; Zhu, X | 1 |
Granberg, S | 1 |
Jin, X; Liu, X; Wu, X; Xu, X | 1 |
Fu, Z; Ji, C; Ling, J; Wu, J; Wu, X; Xu, Q | 1 |
Baktiroglu, M; Dogan, Y; Kahramanoglu, I; Karateke, A; Senol, T; Suer, N | 1 |
Abraham, T; Arian, SE; Bartels, CB; Cayton, KC; Chuong, FS; Holthouser, K; Segars, JH | 1 |
Centini, G; Kashani, BN; Morelli, SS; Petraglia, F; Weiss, G | 1 |
Bahamondes, L; Bahamondes, MV; Monteiro, I | 1 |
Gaetje, R | 1 |
Caglar, GS; Cengiz, H; Gunes, M; Kayikcioglu, F; Tasci, Y; Yagci, B | 1 |
Loisel, C; Marpeau, L; Puscasiu, L; Roman, H; Sentilhes, L | 1 |
Cebi, M; Murat Naki, M; Ozcan, N; Tekcan, C | 1 |
Maruo, T | 1 |
Curtis, KM; Jamieson, DJ; Marchbanks, PA; Tepper, NK; Whiteman, MK; Zapata, LB | 1 |
Luo, L; Qiu, L; Xu, C; Xu, Q; Zhu, L | 1 |
Chen, W; Maruo, T; Nakabayashi, K; Ohara, N; Sasaki, H; Xu, Q; Yamada, H; Yoshida, S | 1 |
Blidaru, I; Boiculese, L; Miron, N; Socolov, D; Socolov, R; Tamba, B | 1 |
Agarwal, N; Awasthi, D; Kriplani, A; Kulshrestha, V | 1 |
Gemzell-Danielsson, K; Heikinheimo, O | 1 |
Bouchard, P | 1 |
Cai, HL; Ding, XC; Li, Q; Qian, RR; Sun, LM; Yu, RF | 1 |
Chen, J; Wan, S; Xie, ZW; Xu, WZ; Zhang, YN | 1 |
Ekholm, E; Grenman, S; Hurskainen, R; Inki, P; Kivelä, A; Kujansuu, E; Paavonen, J; Palo, P; Teperi, J; Yliskoski, M | 1 |
Ikomi, A; Pepra, EF | 1 |
Bifulco, G; Cerrota, G; De Simone, R; Di Spiezio Sardo, A; Mercorio, F; Nappi, C; Vanacore, F | 1 |
Chen-Mok, M; Grigorieva, V; Mikhailov, A; Tarasova, M | 1 |
Eizenberg, DH | 1 |
Mercorio, F | 1 |
Cândido dos Reis, FJ; de Sá Rosa e Silva, AC; Ferriani, RA; Manetta, LA; Nogueira, AA; Rosa e Silva, JC | 1 |
McGavigan, CJ; Owen, P | 1 |
Brosens, I; Farquhar, C | 1 |
Rabinovici, J; Stewart, EA | 1 |
Aldrighi, JM; de Lima, GR; Magalhães, J | 1 |
Kaunitz, AM | 1 |
Chen, W; Johansson, ED; Maruo, T; Matsuo, H; Ohara, N; Sitruk-Ware, R; Xu, Q | 1 |
Jindabanjerd, K; Taneepanichskul, S | 1 |
Higgins, M; Kelehan, P; O'Herlihy, C; Rizkalla, HF | 1 |
Osborn, RA; Wren, BG | 1 |
Coleman, M; Farquhar, C; McCowan, L | 1 |
Alfthan, H; Lehtovirta, P; Stenman, UH; Vartiainen, J | 1 |
Fong, YF; Singh, K | 1 |
Brechin, S; Cameron, ST; Critchley, HO; Paterson, AM; Williams, AR | 1 |
Iwanicki, M; Starczewski, A | 1 |
Schacht, E; Wildemeersch, D | 1 |
Hertz, R; Spiro, I; Zook, BC | 1 |
Collins, DC; Gould, KG; Mann, DR; Schleicher, RL | 1 |
Kirk, ME; Nisker, JA; Nunez-Troconis, JT | 1 |
Tiltman, AJ | 1 |
20 review(s) available for levonorgestrel and Uterine Neoplasms
Article | Year |
---|---|
Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).
Topics: Adult; Antineoplastic Agents, Hormonal; Bias; Contraceptives, Oral; Desogestrel; Female; Goserelin; Humans; Intrauterine Devices, Medicated; Leiomyoma; Leuprolide; Levonorgestrel; Lynestrenol; Medroxyprogesterone Acetate; Menstruation; Middle Aged; Nandrolone; Norethindrone Acetate; Premenopause; Progestins; Randomized Controlled Trials as Topic; Tumor Burden; Uterine Neoplasms | 2020 |
Progestogens or progestogen-releasing intrauterine systems for uterine fibroids.
Topics: Antineoplastic Agents, Hormonal; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Leuprolide; Levonorgestrel; Lynestrenol; Medroxyprogesterone Acetate; Menstruation; Premenopause; Progestins; Randomized Controlled Trials as Topic; Tumor Burden; Uterine Neoplasms | 2013 |
[Hormonal treatments for hemorrhaging secondary to fibroids. An alternative or complement to surgery?].
Topics: Combined Modality Therapy; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Estrogen Receptor Modulators; Estrogens; Female; Humans; Hysterectomy; Leiomyoma; Levonorgestrel; Norpregnenes; Progesterone; Progestins; Treatment Outcome; Uterine Hemorrhage; Uterine Neoplasms | 2013 |
Indications and alternatives to hysterectomy.
Topics: Adenomyosis; Aromatase Inhibitors; Chronic Pain; Endometrial Hyperplasia; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Hysteroscopy; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Pelvic Pain; Polyps; Uterine Artery Embolization; Uterine Diseases; Uterine Hemorrhage; Uterine Myomectomy; Uterine Neoplasms | 2014 |
Selective progesterone receptor modulators: an update.
Topics: Adenomyosis; Animals; Clinical Trials as Topic; Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Postcoital; Endometriosis; Estrenes; Female; Hormone Antagonists; Humans; Leiomyoma; Levonorgestrel; Mifepristone; Norpregnadienes; Oximes; Receptors, Progesterone; Uterine Neoplasms | 2014 |
Levonorgestrel-releasing intrauterine system use in premenopausal women with symptomatic uterine leiomyoma: a systematic review.
Topics: Antineoplastic Agents, Hormonal; Drug Implants; Drug Screening Assays, Antitumor; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Premenopause; Uterine Neoplasms; Uterus | 2014 |
An Evidence-based Approach to the Medical Management of Fibroids: A Systematic Review.
Topics: Androgens; Aromatase Inhibitors; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Curcumin; Delayed-Action Preparations; Drugs, Chinese Herbal; Estradiol; Estrenes; Estrogen Receptor Antagonists; Evidence-Based Medicine; Female; Fulvestrant; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Neoadjuvant Therapy; Norpregnadienes; Oximes; Plant Extracts; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Tea; Uterine Myomectomy; Uterine Neoplasms; Vitamin D; Vitamins | 2016 |
Role of Medical Management for Uterine Leiomyomas.
Topics: Antifibrinolytic Agents; Aromatase Inhibitors; Cabergoline; Cholecalciferol; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Danazol; Dopamine Agonists; Ergolines; Estrenes; Estrogen Antagonists; Female; Gestrinone; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Mifepristone; Norpregnadienes; Oximes; Patient Care Planning; Selective Estrogen Receptor Modulators; Somatostatin; Tranexamic Acid; Uterine Neoplasms; Vitamins | 2016 |
Levonorgestrel-releasing intrauterine system: uses and controversies.
Topics: Contraception; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometriosis; Endometrium; Estrogen Replacement Therapy; Female; Genital Diseases, Female; HIV Infections; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Risk Assessment; Thrombophilia; Treatment Outcome; Uterine Neoplasms | 2008 |
Intrauterine device use among women with uterine fibroids: a systematic review.
Topics: Contraceptive Agents, Female; Female; Ferritins; Hematocrit; Hemoglobins; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Uterine Hemorrhage; Uterine Neoplasms | 2010 |
Translational research with progesterone receptor modulator motivated by the use of levonorgestrel-releasing intrauterine system.
Topics: Animals; Extracellular Matrix; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Neovascularization, Pathologic; Progesterone; Receptors, Progesterone; Translational Research, Biomedical; Uterine Neoplasms | 2010 |
Emerging indications for the levonorgestrel-releasing intrauterine system (LNG-IUS).
Topics: Contraceptive Agents, Female; Endometrial Hyperplasia; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Uterine Neoplasms | 2012 |
Current and future medical treatments for menometrorrhagia during the premenopause.
Topics: Adolescent; Adult; Contraceptives, Oral; Endometrial Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Levonorgestrel; Menorrhagia; Metrorrhagia; Mifepristone; Norpregnadienes; Polyps; Premenopause; Progestins; Randomized Controlled Trials as Topic; Receptors, Progesterone; Uterine Neoplasms | 2011 |
Efficacy of the levonorgestrel intrauterine system in treating menorrhagia: actualities and ambiguities.
Topics: Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Progesterone Congeners; Uterine Diseases; Uterine Neoplasms | 2002 |
The levonorgestrel-releasing intrauterine system in modern gynaecology.
Topics: Contraceptive Agents, Female; Endometriosis; Female; Hormone Replacement Therapy; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Premenstrual Syndrome; Uterine Hemorrhage; Uterine Neoplasms | 2005 |
Medical and surgical management of adenomyosis.
Topics: Aromatase Inhibitors; Contraceptive Agents, Female; Danazol; Endometriosis; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Uterine Diseases; Uterine Neoplasms | 2006 |
New interventional techniques for adenomyosis.
Topics: Adult; Contraceptives, Oral, Synthetic; Danazol; Diagnosis, Differential; Embolization, Therapeutic; Endometriosis; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Gynecologic Surgical Procedures; Humans; Infertility, Female; Intrauterine Devices, Medicated; Levonorgestrel; Magnetic Resonance Imaging; Menorrhagia; Middle Aged; Minimally Invasive Surgical Procedures; Pregnancy; Uterine Diseases; Uterine Neoplasms | 2006 |
Progestin-releasing intrauterine systems and leiomyoma.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Randomized Controlled Trials as Topic; Receptors, Progesterone; Uterine Neoplasms | 2007 |
Effects of levonorgestrel-releasing IUS and progesterone receptor modulator PRM CDB-2914 on uterine leiomyomas.
Topics: Contraceptive Agents, Female; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Norpregnadienes; Progesterone; Receptors, Progesterone; Uterine Neoplasms | 2007 |
The levonorgestrel-releasing intrauterine device: a wider role than contraception.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menstruation Disturbances; Uterine Neoplasms | 1997 |
3 trial(s) available for levonorgestrel and Uterine Neoplasms
Article | Year |
---|---|
Levonorgestrel-releasing intrauterine device use as an alternative to surgical therapy for uterine leiomyoma.
Topics: Adult; Amenorrhea; Female; Hemoglobins; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Middle Aged; Prospective Studies; Uterine Neoplasms | 2015 |
Levonorgestrel releasing-intrauterine system for the treatment of menorrhagia and/or frequent irregular uterine bleeding associated with uterine leiomyoma.
Topics: Adult; Contraceptive Agents, Female; Device Removal; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Middle Aged; Organ Size; Patient Satisfaction; Severity of Illness Index; Treatment Outcome; Tumor Burden; Ultrasonography; Uterine Hemorrhage; Uterine Neoplasms; Uterus | 2011 |
Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy.
Topics: Adult; Female; Humans; Hysterectomy; Leiomyoma; Levonorgestrel; Menorrhagia; Middle Aged; Ovarian Cysts; Ovary; Progesterone Congeners; Prospective Studies; Ultrasonography; Uterine Neoplasms; Uterus; Vagina | 2002 |
42 other study(ies) available for levonorgestrel and Uterine Neoplasms
Article | Year |
---|---|
Effect of Hysteroscopic Polypectomy Combined with Mirena Placement on Postoperative Adverse Reactions and Recurrence Rate of Endometrial Polyps: Based on a Large-Sample, Single-Center, Retrospective Cohort Study.
Topics: Endometrium; Female; Humans; Hysteroscopy; Levonorgestrel; Polyps; Pregnancy; Retrospective Studies; Uterine Neoplasms | 2022 |
Systemic Progestins and Progestin-Releasing Intrauterine Device Therapy for Premenopausal Patients With Endometrial Intraepithelial Neoplasia.
Topics: Endometrial Hyperplasia; Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Progestins; Uterine Neoplasms; Venous Thromboembolism | 2023 |
Alleviation of Symptoms and Improvement of Endometrial Receptivity Following Laparoscopic Adenomyoma Excision and Secondary Therapy with the Levonorgestrel-releasing Intrauterine System.
Topics: Adenomyoma; Adult; Chemotherapy, Adjuvant; Combined Modality Therapy; Contraceptive Agents, Female; DNA Methylation; Female; Gynecologic Surgical Procedures; Homeobox A10 Proteins; Humans; Intrauterine Devices, Medicated; Laparoscopy; Levonorgestrel; Promoter Regions, Genetic; Treatment Outcome; Uterine Neoplasms | 2020 |
Hysteroscopic management of endometrial polyps and submucous leiomyomas in women using a levonorgestrel-releasing intrauterine system.
Topics: Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Polyps; Uterine Hemorrhage; Uterine Neoplasms | 2022 |
Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228.
Topics: Antifibrinolytic Agents; Contraceptive Agents, Hormonal; Endometrial Ablation Techniques; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Tranexamic Acid; Uterine Artery Embolization; Uterine Hemorrhage; Uterine Myomectomy; Uterine Neoplasms; Watchful Waiting | 2021 |
Postoperative maintenance levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyoma.
Topics: Adenomyoma; Adult; CA-125 Antigen; Dysmenorrhea; Female; Follow-Up Studies; Gonadotropin-Releasing Hormone; Hemoglobins; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Organ Sparing Treatments; Pain Measurement; Postoperative Period; Retrospective Studies; Treatment Outcome; Uterine Neoplasms | 2018 |
Successful laparotomy tumor resection and levonorgestrel-releasing intrauterine system for atypical polypoid adenomyoma.
Topics: Adenomatous Polyps; Adenomyoma; Adult; Contraceptive Agents, Female; Female; Gynecologic Surgical Procedures; Humans; Intrauterine Devices, Medicated; Laparotomy; Levonorgestrel; Uterine Neoplasms | 2019 |
The levonorgestrel-releasing intrauterine system: its effect on the number of hysterectomies performed in perimenopausal women with uterine fibroids.
Topics: Adult; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Longitudinal Studies; Middle Aged; Patient Satisfaction; Perimenopause; Prospective Studies; Uterine Hemorrhage; Uterine Neoplasms | 2013 |
Management of abnormal uterine bleeding in women with mechanical heart valve prosthesis and anticoagulant therapy.
Topics: Adult; Anticoagulants; Catheter Ablation; Contraceptive Agents, Female; Female; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Hysterectomy; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Middle Aged; Prospective Studies; Uterine Hemorrhage; Uterine Neoplasms | 2011 |
Are two intrauterine contraceptive devices better than one?
Topics: Contraceptive Agents, Female; Diagnostic Errors; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Middle Aged; Ultrasonography; Uterine Neoplasms; Uterus | 2014 |
[Effects of levonorgestrel intrauterine system on the expressions of estrogen receptor, progesterone receptor and insulin-like growth factor-1].
Topics: Female; Humans; Immunohistochemistry; Insulin-Like Growth Factor I; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Polyps; Receptors, Estrogen; Receptors, Progesterone; Somatomedins; Uterine Neoplasms | 2014 |
Effects of miRNA-197 overexpression on proliferation, apoptosis and migration in levonorgestrel treated uterine leiomyoma cells.
Topics: Adult; Apoptosis; Cell Movement; Cell Proliferation; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Leiomyoma; Levonorgestrel; MicroRNAs; Middle Aged; Tumor Cells, Cultured; Uterine Neoplasms | 2015 |
[Menorrhagy].
Topics: Adolescent; Adult; Age Factors; Embolization, Therapeutic; Female; Humans; Hysterectomy; Intrauterine Devices; Levonorgestrel; Menorrhagia; Middle Aged; Progestins; Uterine Neoplasms | 2008 |
Treatment of menorrhagia with the levonorgestrel releasing intrauterine system: effects on ovarian function and uterus.
Topics: Adult; Contraceptives, Oral, Synthetic; Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Luteinizing Hormone; Menorrhagia; Middle Aged; Ovary; Regression Analysis; Uterine Neoplasms; Uterus | 2009 |
[Management of menometrorrhagia in women with and without pregnancy intention: hierarchy of therapies].
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Contraceptives, Oral, Hormonal; Embolization, Therapeutic; Endometrial Hyperplasia; Estrogens; Female; Humans; Hysterectomy; Infertility, Female; Leiomyoma; Levonorgestrel; Metrorrhagia; Polyps; Pregnancy; Progestins; Tranexamic Acid; Uterine Neoplasms; Uterus | 2008 |
Levonorgestrel-releasing intrauterine device insertion ameliorates leiomyoma-dependent menorrhagia among women of reproductive age without a significant regression in the uterine and leiomyoma volumes.
Topics: Adult; Age Factors; Delayed-Action Preparations; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Middle Aged; Treatment Outcome; Uterine Neoplasms; Uterus; Young Adult | 2010 |
ACOG Practice Bulletin No. 110: noncontraceptive uses of hormonal contraceptives.
Topics: Acne Vulgaris; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Dysmenorrhea; Endometriosis; Female; Genital Diseases, Female; Hirsutism; Humans; Leiomyoma; Levonorgestrel; Menstruation; Ovarian Cysts; Premenstrual Syndrome; Uterine Neoplasms | 2010 |
Translational research in women's health: from bedside to bench and from bench to bedside.
Topics: Apoptosis; Clinical Trials as Topic; Female; Humans; Intrauterine Devices; Leiomyoma; Levonorgestrel; Menorrhagia; Norpregnadienes; Proliferating Cell Nuclear Antigen; Receptors, Progesterone; Translational Research, Biomedical; Uterine Neoplasms; Women's Health | 2010 |
Levonorgestrel inhibits proliferation and induces apoptosis in uterine leiomyoma cells.
Topics: Adult; Apoptosis; Cell Proliferation; Contraceptive Agents, Female; Female; Formazans; Histocytochemistry; Humans; Inhibitor of Apoptosis Proteins; Insulin-Like Growth Factor I; Leiomyoma; Levonorgestrel; Microscopy, Electron, Transmission; Microtubule-Associated Proteins; Middle Aged; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Survivin; Tetrazolium Salts; Tumor Cells, Cultured; Uterine Neoplasms | 2010 |
Efficacy of the levonorgestrel-releasing intrauterine system in uterine leiomyoma.
Topics: Adult; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Middle Aged; Prospective Studies; Treatment Outcome; Uterine Neoplasms | 2012 |
[Effects of levonorgestrel intrauterine system on endometrial tissue after endometrial polyps resection by hysteroscopy].
Topics: Adult; Endometrium; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Polyps; Postoperative Period; Uterine Neoplasms | 2012 |
Levonorgestrel-releasing intrauterine device is an efficacious contraceptive for women with leiomyoma.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Menstruation; Middle Aged; Uterine Neoplasms | 2012 |
The effect of a levonorgestrel-releasing intrauterine device in the treatment of myoma-related menorrhagia.
Topics: Adult; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Progesterone Congeners; Uterine Neoplasms | 2003 |
Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas.
Topics: Adult; Female; Hemoglobins; Humans; Leiomyoma; Levonorgestrel; Menstruation; Middle Aged; Prospective Studies; Uterine Hemorrhage; Uterine Neoplasms | 2003 |
Update on treatment of menstrual disorders.
Topics: Adult; Contraceptive Agents, Female; Cost-Benefit Analysis; Embolization, Therapeutic; Female; Humans; Hysterectomy, Vaginal; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Menstruation Disturbances; Middle Aged; Uterine Neoplasms | 2003 |
Differing results for efficacy--sampling bias or purposive sampling?
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Leiomyoma; Levonorgestrel; Selection Bias; Treatment Outcome; Uterine Hemorrhage; Uterine Neoplasms | 2003 |
Use of a levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas.
Topics: Adult; Anemia; Blood Flow Velocity; Contraceptive Agents, Female; Female; Hemoglobins; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Myoma; Time Factors; Uterine Hemorrhage; Uterine Neoplasms; Uterus | 2005 |
Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
Topics: Adult; Amenorrhea; Cohort Studies; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Menstruation; Middle Aged; Oligomenorrhea; Prospective Studies; Time Factors; Treatment Outcome; Uterine Neoplasms; Uterus | 2007 |
The use of levonorgestrel - IUD in the treatment of uterine myoma in Thai women.
Topics: Adult; Contraceptives, Oral, Synthetic; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Middle Aged; Myoma; Prospective Studies; Thailand; Time Factors; Uterine Neoplasms; Uterus | 2006 |
Pathological findings associated with the presence of a mirena intrauterine system at hysterectomy.
Topics: Endometrial Hyperplasia; Endometriosis; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Retrospective Studies; Treatment Failure; Uterine Neoplasms; Uterus | 2008 |
Long-acting progestins--promise and prospects.
Topics: Animals; Bibliographies as Topic; Breast Neoplasms; Contraceptives, Oral, Combined; Delayed-Action Preparations; Dogs; Female; Haplorhini; Humans; Injections, Intramuscular; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Progesterone Congeners; Rats; Reproduction; Uterine Neoplasms | 1983 |
The value of endometrial cell sampling in the management of post-menopausal women.
Topics: Cytodiagnosis; Dilatation and Curettage; Endometrial Hyperplasia; Endometrium; Estrogens; Female; Humans; Levonorgestrel; Menopause; Norgestrel; Polyps; Stereoisomerism; Uterine Neoplasms | 1981 |
Identification of choriocarcinoma by the hCG beta-to-hCG proportion in patients with delayed diagnosis caused by contraceptive use.
Topics: Adult; Choriocarcinoma; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Contraceptive Agents, Female; Drug Implants; Female; Fluorescent Antibody Technique; Humans; Intrauterine Devices; Levonorgestrel; Pregnancy; Time Factors; Treatment Outcome; Uterine Hemorrhage; Uterine Neoplasms | 1998 |
Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient.
Topics: Adult; Blood Transfusion; Contraceptive Agents, Female; Dysmenorrhea; Female; Hematinics; Hemoglobins; Humans; Intrauterine Devices, Medicated; Kidney Transplantation; Leiomyoma; Levonorgestrel; Menorrhagia; Ovary; Ultrasonography; Uterine Neoplasms; Uterus | 1999 |
Intrauterine polyps--a cause of unscheduled bleeding in women using the levonorgestrel intrauterine system: case report.
Topics: Adult; Aged; Contraceptive Agents, Female; Endometrial Neoplasms; Female; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Polyps; Uterine Hemorrhage; Uterine Neoplasms | 2000 |
[Intrauterine therapy with levonorgestrel releasing IUD of women with hypermenorrhea secondary to uterine fibroids].
Topics: Adult; Contraceptives, Oral, Synthetic; Drug Administration Routes; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Uterine Neoplasms | 2000 |
Post-marketing surveillance of Norplant contraceptive implants: I. Contraceptive efficacy and reproductive health.
Topics: Abdominal Pain; Adult; Breast Neoplasms; Contraceptive Agents, Female; Developing Countries; Drug Implants; Female; Fertility; Humans; Intrauterine Devices, Copper; Levonorgestrel; Marital Status; Ovarian Cysts; Pelvic Inflammatory Disease; Pregnancy; Pregnancy, Ectopic; Product Surveillance, Postmarketing; Prospective Studies; Sterilization, Tubal; Uterine Cervical Neoplasms; Uterine Hemorrhage; Uterine Neoplasms; Vaginal Discharge; Vaginitis | 2001 |
The effect on menstrual blood loss in women with uterine fibroids of a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Topics: Adult; Drug Delivery Systems; Drug Implants; Female; Humans; Leiomyoma; Levonorgestrel; Menorrhagia; Middle Aged; Pilot Projects; Ultrasonography; Uterine Neoplasms; Uterus | 2002 |
Malignant neoplasms of decidual origin (deciduosarcomas) induced by estrogen-progestin-releasing intravaginal devices in rabbits.
Topics: Animals; Contraceptive Agents, Female; Decidua; Drug Combinations; Drug Implants; Endometrium; Estradiol; Female; Hydatidiform Mole, Invasive; Levonorgestrel; Male; Mice; Mice, Nude; Microscopy, Electron; Norgestrel; Ovary; Polyps; Pregnancy; Rabbits; Silicone Elastomers; Spleen; Uterine Neoplasms; Uterus | 1987 |
Serum levels of cholesterol and lipoproteins in rhesus monkeys: comparison of the effect of gonadotropin-releasing hormone agonist and the progestin, levonorgestrel.
Topics: Animals; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Endometriosis; Female; Gonadotropin-Releasing Hormone; Levonorgestrel; Lipoproteins; Lipoproteins, VLDL; Macaca mulatta; Norgestrel; Uterine Neoplasms | 1987 |
Reduced incidence of rabbit endometrial neoplasia with levonorgestrel implant.
Topics: Animals; Biopsy; Dimethylpolysiloxanes; Drug Implants; Female; Levonorgestrel; Norgestrel; Rabbits; Random Allocation; Uterine Neoplasms | 1988 |
The effect of progestins on the mitotic activity of uterine fibromyomas.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Follow-Up Studies; Humans; Leiomyoma; Levonorgestrel; Medroxyprogesterone; Middle Aged; Mitosis; Norethindrone; Norgestrel; Uterine Neoplasms; Uterus | 1985 |